Last reviewed · How we verify
"Basel phenotyping cocktail" capsule — Competitive Intelligence Brief
marketed
Pharmacogenomics / Clinical Pharmacology
Small molecule
Live · refreshed every 30 min
Target snapshot
"Basel phenotyping cocktail" capsule ("Basel phenotyping cocktail" capsule) — University Hospital, Basel, Switzerland. A diagnostic cocktail containing probe drugs that assess the activity of multiple cytochrome P450 enzymes and other drug-metabolizing pathways in vivo.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| "Basel phenotyping cocktail" capsule TARGET | "Basel phenotyping cocktail" capsule | University Hospital, Basel, Switzerland | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- "Basel phenotyping cocktail" capsule CI watch — RSS
- "Basel phenotyping cocktail" capsule CI watch — Atom
- "Basel phenotyping cocktail" capsule CI watch — JSON
- "Basel phenotyping cocktail" capsule alone — RSS
Cite this brief
Drug Landscape (2026). "Basel phenotyping cocktail" capsule — Competitive Intelligence Brief. https://druglandscape.com/ci/basel-phenotyping-cocktail-capsule. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab